Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults-any news?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 20, Issue 2, 2017, Pages 104-109

  Cederholm, Tommy ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; cognition; omega 3 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; CLINICAL DEMENTIA RATING; COGNITION; COGNITIVE FUNCTION TEST; DEMENTIA; DIET SUPPLEMENTATION; FISH MEAT; FOOD INTAKE; HUMAN; MENTAL DETERIORATION; META ANALYSIS (TOPIC); MINI MENTAL STATE EXAMINATION; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; AGED; ANIMAL; COGNITIVE DEFECT; DIETARY SUPPLEMENT; EATING; FISH; MIDDLE AGED;

AGED; ALZHEIMER DISEASE; ANIMALS; COGNITIVE DYSFUNCTION; DEMENTIA; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EATING; FATTY ACIDS, OMEGA-3; FISHES; HUMANS; MIDDLE AGED;

EID: 85004045192     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000350     Document Type: Review

References (27)

1. Cederholm T, Salem N Jr, Palmblad J. Omega-3 fatty acids in the prevention of cognitive decline in humans. Adv Nutr 2013; 4:672-676.
2. Dangour AD, Allen E, Elbourne D, et al. Effect of 2-y n-3 long-chain poly-unsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 2010; 91:1725-1732.
3. Morris MC, Brockman J, Schneider JA, et al. Association of seafood consumption, brain mercury level, and APOE e4 status with brain neuropathology in older adults. JAMA 2016; 315:489-497.
4. Nishihira J, Tokashiki T, Higashiuesato Y, et al. Associations between serum omega-3 fatty acid levels and cognitive functions among community-dwelling octogenarians in Okinawa, Japan: the KOCOA study. J Alzheimers Dis 2016; 51:857-866.
5. Chew EY, Clemons TE, Agrón E, et al. Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial. JAMA 2015; 314:791-801.
6. Külzow N, Witte AV, Kerti L, et al. Impact of omega-3 fatty acid supplementation on memory functions in healthy older adults. J Alzheimers Dis 2016; 51:713-725.
7. Wu S, Ding Y, Wu F, et al. Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis. Neurosci Biobehav Rev 2015; 48:1-9.
8. Zhang Y, Chen J, Qiu J, et al. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. Am J Clin Nutr 2016; 103:330-340.
9. Phillips MA, Childs CE, Calder PC, Rogers PJ. No effect of omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impair ment and probable Alzheimer's disease: a randomised controlled trial. Int J Mol Sci 2015; 16:24600-24613.
10. Boespflug EL, McNamara RK, Eliassen JC, et al. Fish oil supplementation increases event-related posterior cingulate activation in older adults with subjective memory impairment. J Nutr Health Aging 2016; 20:161-169.
11. Yamagishi K, Ikeda A, Chei CL, et al. Serum a-linolenic and other v-3 fatty acids, and risk of disabling dementia: community-based nested case-control study. Clin Nutr 2016; doi: 10.1016/j.clnu.2016.05.011 [Epub ahead of print]
12. Hashimoto M, Kato S, Tanabe Y, et al. Beneficial effects of dietary docosa-hexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes. Geriatr Gerontol Int 2016; doi: 10.1111/ggi.12691 [Epub ahead of print]
13. Eriksdotter M, Vedin I, Falahati F, et al. Plasma fatty acid profiles in relation to cognition and gender in Alzheimer's disease patients during oral omega-3 fatty acid supplementation: the OmegAD study. J Alzheimers Dis 2015; 48:805-812.
14. Burckhardt M, Herke M, Wustmann T, et al. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev 2016; CD009002.
15. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006; 63:1402-1408.
16. Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010; 304:1903-1911.
17. Shinto L, Quinn J, Montine T, et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis 2014; 38:111-120.
18. Oulhaj A, Jernerén F, Refsum H, et al. Omega-3 fatty acid status enhances the prevention of cognitive decline by B vitamins in mild cognitive impairment. J Alzheimers Dis 2015; 50:547-557.
19. Gill SS, Seitz DP. Lifestyles and cognitive health: what older individuals can do to optimize cognitive outcomes. JAMA 2015; 314:774-775.
20. Cao L, Tan L, Wang HF, et al. Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies. Mol Neurobiol 2016; 53:6144-6154.
21. Mohajeri MH, Troesch B, Weber P. Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia. Nutrition 2015; 31:261-275.
22. Salem N Jr, Vandal M, Calon F. The benefit of docosahexaenoic acid for the adult brain in aging and dementia. Prostaglandins Leukot Essent Fatty Acids 2015; 92:15-22.
23. Grimm MO, Haupenthal VJ, Mett J, et al. Oxidized docosahexaenoic acid species and lipid peroxidation products increase amyloidogenic amyloid precursor protein processing. Neurodegener Dis 2016; 16:44-54.
24. Wang X, Hjorth E, Vedin I, et al. Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study. J Lipid Res 2015; 56:674-681.
25. Fiala M, Halder RC, Sagong B, et al. v-3 supplementation increases amyloid-b phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J 2015; 29:2681-2689.
26. Zhu M, Wang X, Hjorth E, et al. Pro-resolving lipid mediators improve neuronal survival and increase Ab42 phagocytosis. Mol Neurobiol 2016; 53:2733-2749.
27. Fiala M, Terrando N, Dalli J. Specialized pro-resolving mediators from omega-3 fatty acids improve amyloid-b phagocytosis and regulate inflammation in patients with minor cognitive impairment. J Alzheimers Dis 2015; 48:293-301.